1. AB0239 EFFECTS OF DYSMETABOLISMS AND COMORBIDITIES ON THE EFFICACY, SAFETY AND RETENTION RATE OF BIOLOGICAL DMARDS (bDMARD) IN INFLAMMATORY JOINT DISEASES. (2nd June 2020) Authors: Cometi, L.; Bruni, C.; Chiti, N.; Tofani, L.; Nacci, F.; Bartoli, F.; Bellando Randone, S.; Fiori, G.; Guiducci, S.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0281 SAFETY AND RETENTION RATE AFTER SWITCHING FROM ETANERCEPT ORIGINATOR (ETN) TO ETANERCEPT BIOSIMILAR (SB4) IN INFLAMMATORY JOINT DISEASES: DATA FROM REAL LIFE. (2nd June 2020) Authors: Bruni, C.; Gentileschi, S.; Capassoni, M.; Pacini, G.; Bardelli, M.; Baldi, C.; Tofani, L.; Cometi, L.; Nacci, F.; Bartoli, F.; Fiori, G.; Cantarini, L.; Guiducci, S.; Frediani, B.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0361 EFFICACY AND SAFETY OF BARICITINIB (BARI) IN RHEUMATOID ARTHRITIS(RA): CLINICAL AND ULTRASOUND EVALUATION IN REAL LIFE. (2nd June 2020) Authors: Tesei, G.; Bruni, C.; Cometi, L.; Nacci, F.; Capassoni, M.; Terenzi, R.; Tofani, L.; Bartoli, F.; Fiori, G.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0466 Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides. (23rd January 2014) Authors: Peruzzi, F.; Bartalesi, F.; Attala, L.; Cavallo, A.; Fiori, G.; Maddali-Bongi, S.; Bruni, C.; Nacci, F.; Bartoli, F.; Cappelli, S.; Denaro, V.; Bartoloni, A.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0519 Systemic Sclerosis Sera Affect in Vitro Angiogenesis, Wound Healing Capacity and Migration of Dermal Blood Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide. (10th June 2014) Authors: Manetti, M.; Borghini, A.; Nacci, F.; Romano, E.; Milia, A.F.; Guiducci, S.; Matucci-Cerinic, M.; Ibba-Manneschi, L.; Weber, E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P997First experience in 19 months attain stability lv-lead extraction. (20th June 2017) Authors: Mandurino, C.; Pinto, M.; Guido, A.; Sgarra, L.; Santobuono, VE.; Memeo, R.; Nacci, F.; Anaclerio, M.; Luzzi, G.; Favale, S. Journal: Europace Issue: Volume 19(2017)Supplement 3 Page Start: iii209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0129 Incidence and clinical outcome of anti-drug antibodies in infliximab-treated patients. (23rd January 2014) Authors: Bartoli, F.; Fiori, G.; Galluccio, F.; Petroni, G.; Pratesi, S.; Matucci, A.; Vultaggio, A.; Nacci, F.; Nencini, F.; Maggi, E.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0150 Soluble FAS/FASL levels in rheumatoid arthritis patients treated with infliximab and adalimumab. (23rd January 2014) Authors: Terenzi, R.; Guiducci, S.; Nacci, F.; Romano, E.; Manetti, M.; Peruzzi, F.; Bruni, C.; Bartoli, F.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0582 Incidence of Malignancies in Patients with Inflammatory Rheumatic Diseases and Biological Drugs: Experience from One Center in Italy. (15th July 2016) Authors: Bartoli, F.; Bruni, C.; Tesei, G.; Denaro, V.; Nacci, F.; Antonuzzo, L.; Di Costanzo, F.; Matucci-Cerinic, M.; Fiori, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0195 Incidence of Infliximab (IFX) Infusion Reactions with and Without Premedication. (23rd January 2014) Authors: Bartoli, F.; Fiori, G.; Galluccio, F.; Nacci, F.; Salvadorini, G.; Matucci Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗